EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Charles River Laboratories International, Inc. (CRL) EBITDA Margin data is not available.
| Income Statement Financials | |
$994.23M |
|
$-276.56M |
|
$684.54M |
|
$309.68M |
|
$1.28B |
|
$-283.44M |
|
$-10.66M |
|
$-294.10M |
|
$-294.10M |
|
$-276.29M |
|
$-276.29M |
|
$-276.29M |
|
$-276.29M |
|
$-283.44M |
|
$-40.16M |
|
49.56M |
|
49.56M |
|
$-5.58 |
|
$-5.57 |
|
| Balance Sheet Financials | |
$1.45B |
|
$1.66B |
|
$5.69B |
|
$7.14B |
|
$1.12B |
|
$2.14B |
|
$2.85B |
|
$3.97B |
|
$3.17B |
|
$65.68M |
|
$3.17B |
|
49.22M |
|
| Cash Flow Statement Financials | |
$737.65M |
|
$-209.32M |
|
$-536.73M |
|
$205.57M |
|
$216.00M |
|
$10.43M |
|
$71.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.29 |
|
-- |
|
-- |
|
0.40 |
|
0.67 |
|
31.15% |
|
-28.51% |
|
-28.51% |
|
|
EBITDA Margin |
-- |
-29.58% |
|
-27.82% |
|
$518.49M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
2.29 |
|
1.40 |
|
64.17 |
|
-8.72% |
|
-420.64% |
|
-3.87% |
|
-5.21% |
|
$64.41 |
|
$10.46 |
|
$14.88 |
|